Scholarship Awards for the Meeting Synaptopathies in Neurodevelopmental Disorders: SHANK Mutations as a Window Into Synaptic Function
Scholarship Awards for the Meeting Synaptopathies in Neurodevelopmental Disorders: SHANK Mutations as a Window Into Synaptic Function Thursday, November 13, 2014 1:00 PM - Friday, November 14, 2014 6:00 PM (Eastern Time) Washington, DC Abstracts are due October 5, 2014. Join us at the "SHANK Symposium" in Washington, DC, a Satellite Event prior to the Society of Neuroscience 2014 Meeting Synaptic dysfunction represents a major cause of autism, intellectual disability, epilepsy, and schizophrenia.  These disorders frequently show deleterious mutations in genes encoding synaptic proteins, providin...
Source: ScanGrants feed - September 29, 2014 Category: Research Authors: Phelan-McDermid Syndrome Foundation Source Type: funding

Jerome Lejeune Foundation Grants Program
The Jerome Lejeune Foundation is the world’s oldest and largest private funder of research into treatments for intellectual disabilities of genetic origin, especially, but not limited to, Down syndrome. The Foundation’s specific research interest is to discover a means of  treating genetic intellectual disabilities in order to improve the memory, speech, and cognition of patients. Researchers who are working in basic or applied science and who have genetic intellectual disabilities (Down syndrome, Fragile X syndrome, Cri-du-Chat syndrome, rare chromosomal anomalies, Rett syndrome, Williams Beuren, Wil...
Source: ScanGrants feed - August 12, 2013 Category: Research Authors: Jerome Lejeune Foundation Source Type: funding

International Rett Syndrome Foundation Research Fellowship Program
IRSF announces the availability of Mentored Training Fellowships to support scientists early in their career to in both basic and clinical research in the field of Rett syndrome so that they become successful, independent basic research scientists and clinical investigators. These talented researchers will be the future leaders in the Basic, Translational and Clinical research areas for Rett syndrome. The two-year Mentored Training Fellowships in Basic Research and Clinical Research are designed to assist post-doctoral research scientists and clinical scientists establish careers in fields relevant to Rett syndrome re...
Source: ScanGrants feed - January 23, 2013 Category: Research Authors: International Rett Syndrome Foundation Source Type: funding

International Rett Syndrome Foundation Basic Research Grant Program
IRSF announces the availability of Regular Research grants for international biomedical research to promote the understanding of MeCP2 in the pathogenesis of the neurobehavioral phenotype of Rett syndrome (RTT). We seek to gain a better understanding of the underlying pathology of the disorder leading to an amelioration of the symptoms and a cure for RTT. IRSF seeks to encourage research that encompasses innovative therapeutic approaches and state of the art diagnostic techniques. IRSF encourages applications within the following emphasis areas: Understanding the role of MeCP2 during normal brain development Chara...
Source: ScanGrants feed - January 23, 2013 Category: Research Authors: International Rett Syndrome Foundation Source Type: funding

International Rett Syndrome Foundation Translational Research Program
Cycle 2 Letter of Intent due:  July 1, 2013 IRSF announces the availability of HeART (Help Accelerate RTT Therapeutics) and ANGEL (Advanced Neurotherapeutic Grant of Excellence) grant awards to promote the development and testing of therapeutics to treat and reverse Rett syndrome (RTT) and its symptoms. These award mechanisms seek to facilitate the development and testing of novel therapeutics targeting the underlying pathology of the disorder, thereby leading to an amelioration of symptoms or ultimately a pharmacological reversal of RTT. Through these awards, IRSF seeks to foster academic and public-private part...
Source: ScanGrants feed - January 23, 2013 Category: Research Authors: International Rett Syndrome Foundation Source Type: funding

International Rett Syndrome Foundation Translational Research Program
Cycle 1 Letter of Intent due: February 1, 2013 IRSF announces the availability of HeART (Help Accelerate RTT Therapeutics) and ANGEL (Advanced Neurotherapeutic Grant of Excellence) grant awards to promote the development and testing of therapeutics to treat and reverse Rett syndrome (RTT) and its symptoms. These award mechanisms seek to facilitate the development and testing of novel therapeutics targeting the underlying pathology of the disorder, thereby leading to an amelioration of symptoms or ultimately a pharmacological reversal of RTT. Through these awards, IRSF seeks to foster academic and public-private partne...
Source: ScanGrants feed - January 23, 2013 Category: Research Authors: International Rett Syndrome Foundation Source Type: funding